JP Patent

JP5252404B2 — ピラジン化合物、その使用及び調製方法

Assigned to ベーリンガーインゲルハイムインターナショナルゲゼルシャフトミットベシュレンクテルハフツング · Expires 2013-07-31 · 13y expired

What this patent protects

Patent listed against ruxolitinib-phosphate.

Drugs covered by this patent

ruxolitinib-phosphate (RUXOLITINIB PHOSPHATE)

Patent Metadata

Patent number: JP5252404B2
Jurisdiction: JP
Classification: —
Expires: 2013-07-31
Drug substance claim: No
Drug product claim: No
Assignee: ベーリンガーインゲルハイムインターナショナルゲゼルシャフトミットベシュレンクテルハフツング
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.